Health
Oxford University weighing up how vaccine platform would need to adapt to deal with variants – BioPharma-Reporter.com
The team behind the Oxford-AstraZeneca COVID-19 vaccine says it is carefully assessing the impact of new variants from the UK, South Africa and Brazil on vaccine…
It is known that viruses constantly change through mutation, leading to the emergence of new variants, and we should expect many new variants to be identified during 2021.
These changes are being monitored closely by scientists, and it is important we continue to remain vigilant for changes in the future.
The University of Oxford is evaluating the processes needed for rapid development of adjusted COVID-19 vaccines if these should be necessary, a strategic communications manager at the public…
-
Noosa News19 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business21 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business18 hours agoDicker Data rides the AI trend to double digit growth
-
Business21 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy